bioscrip error notbranded occurred regardless we recommend you to update your browser bioscrip inc private company information  bloomberg july    pm et healthcare providers and services company overview of bioscrip inc snapshot people company overview bioscrip inc provides home infusion services in the united states the company engages in the preparation delivery administration and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous subcutaneous intramuscular intraspinal and enteral methods it is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions such as infections nutritional deficiencies immunologic and neurologic disorders cancer pain and palliative care bioscrip inc offers its services at patient’s homes outpatient clinics nursing facilities physician’s offices and ambulatory infusion centers  bioscrip inc provides home infusion services in the united states the company engages in the preparation delivery administration and clinical monitoring of pharmaceutical treatments that are administered to a patient through intravenous subcutaneous intramuscular intraspinal and enteral methods it is primarily involved in the intravenous administration of medications to treat a range of acute and chronic conditions such as infections nutritional deficiencies immunologic and neurologic disorders cancer pain and palliative care bioscrip inc offers its services at patient’s homes outpatient clinics nursing facilities physician’s offices and ambulatory infusion centers the company markets and sells its products and services through sales and marketing representatives payor relationships and other government programs bioscrip inc was founded in  and is based in denver colorado detailed description  broadwaysuite denver co united statesfounded in  employees phone  wwwbioscripcom key executives for bioscrip inc mr daniel e greenleaf chief executive officer president and director age  total annual compensation k mr david evans chief operating officer and senior vice president age  total annual compensation k mr c britt jeffcoat chief accounting officer vice president and controller age  total annual compensation k mr alex schott senior vice president of strategic operations age  total annual compensation k compensation as of fiscal year  bioscrip inc key developments bioscrip inc announces new senior note facilities jun   bioscrip inc announced that the company has entered into an agreement with a group of note purchasers led by funds managed by ares management lp to refinance its existing senior credit facility and priming credit agreement under the agreement the company entered into a  million first lien note facility and a  million second lien note facility facilities upon funding of the facilities at close the company will receive  million and will use the proceeds of the facilities to repay in full all amounts outstanding under its previous senior credit facilities and its priming credit agreement also as part of the agreement the company will receive a  million common stock investment and will issue common stock warrants with a year term cash on hand at close will be in excess of  million and combined with  million of additional availability on the second lien note results in company liquidity in excess of  million the company expects the transaction to close on june   bioscrip provides update on united health care contract reiterates earnings guidance for the year  may   bioscrip inc has reached an agreement to continue to provide certain core product lines to unitedhealthcare beyond september   with this agreement bioscrip will retain approximately  million of annualized profitable core revenue the company continues to collaborate with unitedhealthcare on contract transition plans including its exit from other nonprofitable product lines and will update its  revenue guidance when appropriate the company is reiterating its prior guidance for adjusted ebitda in the range of  million to  million for fullyear  bioscrip inc presents at jefferies  global healthcare conference jun  pm may   bioscrip inc presents at jefferies  global healthcare conference jun  pm venue grand hyatt  e nd st new york new york united states speakers daniel e greenleaf chief executive officer president and director stephen m deitsch chief financial officer senior vice president and treasurer similar private companies by industry company name region  home medical inc united states home approach llc united states home care united states  e pecan grove road llc united states  welsh road operations llc united states recent private companies transactions typedate target private placement june    private placement march    request profile update   the information and data displayed in this profile are created and managed by sp global market intelligence a division of sp global bloombergcom does not create or control the content for inquiries please contact sp global market intelligence directly by clicking here stock quotes market data is delayed at least  minutes company lookup most searched private companies company name geographic region lawyers committee for civil rights under law united states nyc inc united states bertelsmann ag europe the advertising council inc united states rush university united states sponsored financial commentaries sponsored links browse companies a b c d e f g h i j k l m n o p q r s t u v w x y z              request profile update only a company representative may request an update for the company profile documentation will be required to contact bioscrip inc please visit wwwbioscripcom company data is provided by sp global market intelligence please use this form to report any data issues information missing  please enter your information in the following fields company name your name your email address your phone number type of data overview executives key developments similar companies transactions update needed all data changes require verification from public sources please include the correct value or values and a source where we can verify cancel submit your requested update has been submitted our data partners will research the update request and update the information on this page if necessary research and followup could take several weeks if you have questions you can contact them at bwwebmasterbusinessweekcom close   bioscrip buys home solutions strengthens infusion business  september    zackscom join sign in member sign in keep me signed in what does remember me do forgot password create a new account you are being directed to zackstrade a division of lbmz securities and licensed brokerdealer zackstrade and zackscom are separate companies the web link between the two companies is not a solicitation or offer to invest in a particular security or type of security zackstrade does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating indiv idual securities if you wish to go to zackstrade click ok if you do not click cancel ok cancel back to top bioscrip buys home solutions strengthens infusion business zacks equity research september   rdnt usph afam bios trades from  read morehide full article as expected after a minor adjustment to the terms of its earlier announced agreement to acquire hs infusion holdings inc’s home infusion and home nursing products and services business home solutions bioscrip inc bios  free report has finally completed the transactionwe note that in its effort to focus on its infusion services business the company had decided to acquire home solutions in june home solutions particularly caters to patients suffering from chronic and acute medical conditions according to bioscrip the consolidated company will be a stronger player in the infusion services market with the complimentary services and enhanced focus on higher margin core infusion therapieswe note that while the initial closing consideration was  million it was reduced to  million later on the cash component of the consideration was lowered to  million from  millionprice price  quotethe combined company is expected to generate revenues of more than  billion additionally the acquisition while accelerating the company’s growth in core business is likely to generate between − million in cost savings within approximately − months following the completion in terms of operating synergy the inclusion of home solutions will benefit bioscrip with respect to balance sheet and leverage profile supply chain efficiencies infrastructure optimization and other corporate and organizational improvementsas per the latest amendment of the asset purchase agreement to facilitate the timely closure of this transaction bioscrip and home solutions now have to arrange for a shareholder meeting to seek bioscrip stockholder approval to increase its authorized share capital the date of this meeting will be announced accordinglywe note that over the recent past bioscrip has been recording consistent growth in its core infusion services business where it has a strong presence and enjoys a competitive advantage bioscrip has already taken a number of steps to focus on the core infusion business in order to drive further growth thereinthese include the sale of its legacy specialty and mail service pharmacies the divestiture of its home health services business the latest divestment of the pbm business to procare rx and its plan to sell or shift  core patient service activities accumulated through acquisitions to alliance pharmacy providersthe company has been engaged in a series of takeovers and sellouts in recent times as well the latest example being the impending buyout of home solutions further bioscrip continues to evaluate a huge pipeline of acquisition opportunities to further expand its infusion footprint in the uscurrently the company carries a zacks rank  holdkey picks in the sectorbetterranked stocks in the broader medical space are almost family inc afam  free report  radnet inc rdnt  free report and us physical therapy inc usph  free report  all the three stocks carry a zacks rank  buy you can see the complete list of today’s zacks  rank strong buy stocks hereconfidential from zacks beyond this analyst blog would you like to see zacks best recommendations that are not available to the public our executive vp steve reitmeister knows when key trades are about to be triggered and which of our experts has the hottest hand click to see them now indepth zacks research for the tickers above normally  each  click below to receive one report free radnet inc rdnt  free report us physical therapy inc usph  free report almost family inc afam  free report bioscrip inc bios  free report  more from zacks analyst blog mercks biosimilar insulin gets tentative fda approval abbvie incs abbv q earnings disappointment in store canadian national cni q earnings a beat in the cards bank stock roundup enough positive surprises in q despite weakness jpm  bac in focus › ‹ you may like four takeaways from the q earnings season these stocks will struggle should oil  gas prices not pick up top stock reports for alphabet glaxosmithkline  tmobile investors can buy selective energy stocks at bargain prices › ‹ zacks  breakout stocksfor july  free report for zackscom visitors only our experts cut down  zacks rank  strong buys to the  that are most likely to jump in price immediately for  years the full strong buy list has averaged a stellar  per year see its  best stocks now close this panel x up next starwood hot launches sheraton brand hotel in quebec most read biotech bull is back  keys to play it  takeaways from q earnings season buy select energy stocks at bargain prices top stock reports for alphabet glaxo  tmobile friday finish line sears survives netflix  microsoft impress › ‹ bioscrip provides update on unitedhealthcare contracthomemailflickrtumblrnewssportsfinancecelebrityanswersgroupsmobilemoretry yahoo finance on firefox »yahoosearchsearchsign inus markets closedsp  dow  nasdaq listenaetnas ceo mark bertolini on the future of the health care systembertolini shares how a lifethreatening injury shaped his views on health carebioscrip provides update on unitedhealthcare contractglobenewswire•may  reblogsharetweetsharedenver may   globe newswire  bioscrip inc bios bioscrip or the company the largest independent national provider of infusion and home care management solutions today announced that the company has reached an agreement to continue to provide certain core product lines to unitedhealthcare beyond september    with this agreement bioscrip will retain approximately  million of annualized profitable core revenue“we value our relationship with unitedhealthcare and are pleased with the revised mutually beneficial agreement  this new contract demonstrates the value that bioscrip provides to all stakeholders in the healthcare system” said daniel e greenleaf president and chief executive officerthe company continues to collaborate with unitedhealthcare on contract transition plans including its exit from other nonprofitable product lines and will update its  revenue guidance when appropriate  the company is reiterating its prior guidance for adjusted ebitda in the range of  million to  million for fullyear about bioscripbioscrip inc is the largest independent national provider of infusion and home care management solutions with approximately  teammates and nearly  service locations across the us bioscrip partners with physicians hospital systems payors pharmaceutical manufacturers and skilled nursing facilities to provide patients access to postacute care services bioscrip operates with a commitment to bring customerfocused pharmacy and related healthcare infusion therapy services into the home or alternatesite setting by collaborating with the full spectrum of healthcare professionals and the patient bioscrip provides costeffective care that is driven by clinical excellence customer service and values that promote positive outcomes and an enhanced quality of life for those it servesreblogsharetweetsharerecently viewedyour list is emptywhat to read next dudes in a car blissing out in the lincoln continentalyahoo financewhy it might be ‘dangerous’ for ibm to turn itself around professoryahoo financea former biotech executive whos living with terminal cancer wants to reset expectations about new cancer treatmentsbusiness insiderglaxosmithklines new ceo prepares to trim drug pipelinereutersaetna ceo bertolini how tech plays into the future of healthcareyahoo finance videocall of the week nows the time to buy chipotleyahoo financedemocrats herald agreement on sweeping russia sanctions billassociated pressan obscure senate rule just put the gop healthcare bill in even bigger perilbusiness insiderwhat its like to ship yourself overnight on cabins sleep pod bustechcrunchaetna ceo bertolini why he pays his employees to sleepyahoo finance videoshortsellers have lost  billion betting against this years hottest tech stocksyahoo financegm may kill  car models as it works with uaw to tackle sales slumpautoblogmary kay launches beauty industry first as thousands convene for us seminarpr newswiretrump administration pulls health law help in  citiesassociated pressaetna ceo bertolini how his own accident and son’s cancer changed his journeyyahoo finance videostocks back off from record highsyahoo financethe number of people on food stamps is falling here’s whynone it wouldnt surprise me if it also has something to do with illegal aliens being deportedjoin the conversation   bioscrip inc pharmacy manager  smartrecruiters pharmacy manageromaha nefulltimecompany descriptionbioscrip inc bios is one of the nation’s leading specialty infusion and home healthcare companies our focus is clinical excellence and improving the quality of our patients’ lives with over  employees able to service  states bioscrip inc has externallyqualified centers of excellence built around specific clinical conditions and therapies ours is a fastpaced dynamic work environment with room for new ideas and opportunities for career advancement we offer a wide array of employee benefits tuition reimbursement and an excellent k plan with an employer matchjob descriptiondue to our exceptional growth and success we are recruiting for a pharmacy manager to join our team   summaryplans and manages the pharmacy in compliance within all legal and regulatory parameters in cooperation with all other branch departments and as an efficient and profitable business center   essential functionsto perform this job successfully an individual must be able to perform each essential function satisfactorily with or without reasonable accommodationbuilds a highquality serviceoriented pharmacy teamdirects coordinates and evaluates pharmacy staff and carries out supervisory responsibilities in accordance with the organization’s policies and applicable laws responsibilities include interviewing hiring and training employees planning assigning and directing work appraising performance succession planning rewarding and disciplining employees addressing complaints and resolving problemsassures staff training and competencycomplies with human resources policies for department may delegate policy components but retains responsibility for performance and adherencedevelops a pharmacy budget analyzes revenue profit and inventory budgets to monitor performance to budget prepares as requested by the general manager budget requests operating budgets and budget revisionsworks with staff to continually develop and implement ideas for delivering highquality costeffective servicesmanages the daily financial activities of the pharmacy including accounting purchasing and business planningimplements record systems and processes for the operating unitcomplies with state and federal regulations accrediting body standards corporate policies and standards of performance serves as the pharmacist in charge for resident and nonresident state pharmacy licensureoversees pharmacy patient services directly or through a qualified individual with responsibility for policy implementation patient satisfaction and performance improvementparticipates directly in pharmacy services on anneeded basis and as appropriate to qualificationsevaluates and communicates regarding the appropriateness and quality of drugs supplies equipment as well as other products and services selected for use by bioscripmanages compliance to the bioscrip formularymanages reimbursement for products and services in compliance with company policy and goals to include drug supply and equipment selection and utilization and participates in the submission of clean claims through compliance to proper pharmacy billing proceduresmaintains current information as to trends and developments in drugs clinical care and business interests presents recommendations for marketing of programsworks with sales and marketing staff to develop and promote strategies for business growth oversees staff allocation inventory control and other expenses according to performance standardsrepresents the organization at various clinical or sales meetings promotes existing and new programsparticipates in the pharmacy oncall rotationmaintains solid knowledge of and compliance with bioscrip policies and procedureseach employee is responsible for adhering to those performance programs policies procedures guidelines and internal control standards established to guide the operation of the company each employee must be made aware of and understand proper internal control procedures associated with their specific job function as communicated by hisher manager each employee is responsible for reporting concerns that he or she may have with respect to deficiencies in internal controlmanagers and supervisors are responsible for ensuring that internal controls are established and functioning to achieve the mission and objectives of their unit each employee within an area under the manager or supervisor’s direction must be made aware of and understand proper internal control procedures associated with their specific job functionmanagers and supervisors must acknowledge that utilization of internal controls is an inherent part of a manager’s responsibility not a new or additional function and assure that internal controls are supportive of and consistent with the operating mandate and philosophy of the companyperforms other duties as assigned  supervisory responsibilitiesmanagement responsibility for all pharmacy staff may direct subordinate supervisors    physical demandsthe physical demands described here are representative of those that must be met by an employee to successfully perform the essential functions of this job with or without reasonable accommodation  the employee is occasionally required to stand walk sit reach outward and handlefingerthe employee is occasionally required to reach above shoulder climb crawl squat kneel and bendthe employee may be required to pushpull up to lbsthe employee may be required to liftcarry up to lbsspecific vision abilities required by this job include close vision distance vision peripheral vision and the ability to adjust focus  work environmentthe work environment characteristics described here are representative of those an employee encounters while performing the essential functions of this job with or without reasonable accommodation work is normally performed in a typical interioroffice work environment or in a cleanroomchemotherapy is compounded on site compliance with all safety procedures requiredmay occasionally be exposed to moving mechanical partsthe noise level in the work environment is usually quiet to moderate qualificationseducation training and experience requirementsbachelors degree in pharmacy master’s or pharmd preferred current pharmacist licensure in good standing in state of practice minimum of three  years proven supervisory or management experience and at least five  years of experience directly related to the duties and responsibilities specified experiential requirements may be waived in lieu of evidence of progressive growth in and attainment of the skills necessary to perform the required duties   knowledge skills and abilities requiredthe requirements listed below are representative of the knowledge skill andor ability required with or without reasonable accommodation knowledge of local state federal and other regulations applicable to the practice of pharmacy knowledge of regulations and legal requirements governing the industryknowledge of accreditation standards and requirementsworks independently demonstrates leadership in the practice of pharmacyability to supervise and train employees to include organizing prioritizing and scheduling work assignmentsability to foster a cooperative work environmentstrong interpersonal and communication skills and the ability to work effectively with branch departmentsemployee development and performance management skillsknowledge of staff hiring proceduresskill in examining and reengineering operations and procedures developing and implementing new strategies and proceduresknowledge of computerized information systems including financial applicationsknowledge of state federal and commercial infusion pharmacy reimbursementability to develop and maintain recordkeeping systems and proceduresknowledge of current business issues and trendsskill in budget preparation and fiscal managementknowledge of management principles and practicesability to develop and implement financial plans and manage resourcesability to analyze and interpret financial data and prepare financial reports statements andor projectionsknowledge of cash management principles andor proceduresknowledge of marketing strategies processes and available resourcesability to develop plan and implement short and longrange goals  language skillsability to read analyze and interpret pharmacy and clinical information appropriate to duties and responsibilities assigned ability to operate information systems follow policy complete required forms and prepare reports ability to effectively present information and respond to questions from referral sources managers patients employees payors and the general public mathematical skillsability to calculate figures and amounts such as pharmaceutical calculations discounts interest commissions proportions percentages and volume ability to read and interpret profitandloss statements ability to prepare budgets and revenue projections reasoning abilityability to identify problems collect data establish facts and draw valid conclusions ability to interpret an extensive variety of abstract variablesadditional informationbioscrip is an equal opportunity employer  all employment decisions are made without regard to age color race ancestry national origin disability genetic information military status religion creed sex pregnancy childbirth marital status citizenship sexual orientation gender identity gender expression legally protected medical condition or any other basis prohibited by applicable law  background checks and drug screens are part of our hiring process affirmative actionequal opportunity employer minorityfemaledisabledveteranim interestedim interestedrefer a friendposted byrita mckownshare this jobpowered by bioscrip inc  bios  stock price today  zacks bios is up  today but wheres it headed in august privacy policy no cost no obligation to buy anything ever join sign in member sign in keep me signed in what does remember me do forgot password create a new account you are being directed to zackstrade a division of lbmz securities and licensed brokerdealer zackstrade and zackscom are separate companies the web link between the two companies is not a solicitation or offer to invest in a particular security or type of security zackstrade does not endorse or adopt any particular investment strategy any analyst opinionratingreport or any approach to evaluating indiv idual securities if you wish to go to zackstrade click ok if you do not click cancel ok cancel back to top more bioscrip inc bios delayed data from nsdq  usd     updated jul    pm et add to portfolio zacks rank buy          style scores f value  f growth  d momentum  f vgm the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores industry rank bottom  out of  industry medical  outpatient and home healthcare view all zacks  ranked stocks trades from  this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn about the zacks rank zacks rank home  zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank quote overview stock activity open  day low  day high   wk low   wk high  avg volume  market cap  m dividend    beta  key earnings data earnings esp  most accurate est  current qtr est  current yr est  exp earnings date bmo prior year eps  exp eps growth yr forward pe na peg ratio na medical » medical  outpatient and home healthcare bmo  before market open amc  after market close zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings research reports for bios     all zacks’ analyst reports news for bios zacks news for bios other news for bios  breakout stocks offering phenomenal returns am est zacks bioscrip bios strong on infusion reimbursement a drag am est zacks bios what are zacks experts saying now zacks private portfolio services why is bioscrip bios up  since the last earnings report am est zacks dull q earnings  tough industry spell trouble for bioscrip am est zacks bioscrip bios q loss narrower than expected sales miss am est zacks more zacks news for bios bioscrip to host second quarter results call am est globenewswire  breakout stocks offering phenomenal returns am est talkmarkets midday gainers  losers pm est seeking alpha bioscrip announces new senior note facilities am est globenewswire small cap best and worst stocks  thursday june  am est talkmarkets more other news for bios premium research for bios zacks rank buy  zacks industry rank bottom  out of  zacks sector rank bottom   out of  style scores f value  f growth  d momentum  f vgm earnings esp  research reports for bios analyst  snapshot this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to get access to the zacks rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports zacks earnings esp expected surprise prediction looks to find earnings surprises by focusing on the most recent analyst revisions this is done because generally speaking if an analyst reevaluates their earnings estimate right before an earnings release it means that they have fresh information which could potentially be more accurate than what analysts thought about a company two or three months ago the crux of this approach is comparing the most accurate estimate to the zacks consensus estimate although the zacks rank is also an important feature of the esp metric combining these two can help investors find stocks that are ready to beat the consensus at their next report and hopefully surge higher in price too in fact when combining a zacks rank  or better and a positive earnings esp stocks produced a positive surprise  of the time and best of all by using these parameters investors have seen  annual returns on average according to our  year backtest visit the earnings esp center see the full list of stocks to beat earnings this is our short term rating system that serves as a timeliness indicator for stocks over the next  to  months how good is it see rankings and related performance below zacks rank definition annualized return  strong buy   buy   hold   sell   strong sell  sp   zacks rank education  learn more about the zacks rank zacks rank home  all zacks rank resources in one place zacks premium  the only way to fully access the zacks rank the zacks industry rank assigns a rating to each of the  x expanded industries based on their average zacks rank an industry with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s the industry with the best average zacks rank would be considered the top industry  out of  which would place it in the top  of zacks ranked industries the industry with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks industry rank education  learn more about the zacks industry rank the zacks sector rank assigns a rating to each of the  sectors based on their average zacks rank a sector with a larger percentage of zacks rank s and s will have a better average zacks rank than one with a larger percentage of zacks rank s and s zacks sector rank education  learn more about the zacks sector rank the sector with the best average zacks rank would be considered the top sector  out of  which would place it in the top  of zacks ranked sectors the sector with the worst average zacks rank  out of  would place in the bottom  zacks rank education  learn more about the zacks rank zacks sector rank education  learn more about the zacks sector rank the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the three scores are based on the trading styles of growth value and momentum growth score a value score a momentum score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b zacks style scores education  learn more about the zacks style scores the style scores are a complementary set of indicators to use alongside the zacks rank it allows the user to better focus on the stocks that are the best fit for his or her personal trading style the scores are based on the trading styles of value growth and momentum theres also a vgm score v for value g for growth and m for momentum which combines the weighted average of the individual style scores into one score value score a growth score a momentum score a vgm score a within each score stocks are graded into five groups a b c d and f as you might remember from your school days an a is better than a b a b is better than a c a c is better than a d and a d is better than an f as an investor you want to buy stocks with the highest probability of success that means you want to buy stocks with a zacks rank  or  strong buy or buy which also has a score of an a or a b in your personal trading style zacks style scores education  learn more about the zacks style scores the zacks equity research reports or zer for short are our inhouse independently produced research reports the ever popular onepage snapshot reports are generated for virtually every single zacks ranked stock its packed with all of the companys key stats and salient decision making information including the zacks rank zacks industry rank style scores the price consensus  surprise chart graphical estimate analysis and how a stocks stacks up to its peers the detailed multipage analyst report does an even deeper dive on the companys vital statistics in addition to all of the proprietary analysis in the snapshot the report also visually displays the four components of the zacks rank agreement magnitude upside and surprise provides a comprehensive overview of the company business drivers complete with earnings and sales charts a recap of their last earnings report and a bulleted list of reasons to buy or sell the stock it also includes an industry comparison table to see how your stock compares to its expanded industry and the sp  researching stocks has never been so easy or insightful as with the zer analyst and snapshot reports learn more about zacks equity research reports see more zacks equity research reports   change in last  days view all zacks rank  strong buys premium research industry analysis top peers symbol zacks rank bioscrip inc bios amedisys inc amed quorum health corporation qhc us physical therapy inc usph addus homecare corporation adus american renal associates holdings inc ara chemed corp che see all medical  outpatient and home healthcare peers price and eps surprise chart  month  months ytd interactive chart  fundmental chart billion dollar secret company summary bioscrip provides comprehensive pharmaceutical care solutions we partner with healthcare payors pharmaceutical manufacturers government agencies physicians and patients to deliver cost effective programs that enhance the quality of patient life we focus our products and services in two core areas specialty medication distribution and clinical management services both nationally and communitybased and pharmacy benefit management services bioscrip provides update on unitedhealthcare contract nasdaqbios english français register sign in bioscrip provides update on unitedhealthcare contract may    et  source bioscrip inc denver may   globe newswire  bioscrip inc nasdaqbios bioscrip or the company the largest independent national provider of infusion and home care management solutions today announced that the company has reached an agreement to continue to provide certain core product lines to unitedhealthcare beyond september    with this agreement bioscrip will retain approximately  million of annualized profitable core revenue “we value our relationship with unitedhealthcare and are pleased with the revised mutually beneficial agreement  this new contract demonstrates the value that bioscrip provides to all stakeholders in the healthcare system” said daniel e greenleaf president and chief executive officer the company continues to collaborate with unitedhealthcare on contract transition plans including its exit from other nonprofitable product lines and will update its  revenue guidance when appropriate  the company is reiterating its prior guidance for adjusted ebitda in the range of  million to  million for fullyear  about bioscrip bioscrip inc is the largest independent national provider of infusion and home care management solutions with approximately  teammates and nearly  service locations across the us bioscrip partners with physicians hospital systems payors pharmaceutical manufacturers and skilled nursing facilities to provide patients access to postacute care services bioscrip operates with a commitment to bring customerfocused pharmacy and related healthcare infusion therapy services into the home or alternatesite setting by collaborating with the full spectrum of healthcare professionals and the patient bioscrip provides costeffective care that is driven by clinical excellence customer service and values that promote positive outcomes and an enhanced quality of life for those it serves investor contacts stephen deitsch chief financial officer  treasurer t   stephendeitschbioscripcom david clair icr inc t   davidclairicrinccom related articles other press releases by bioscrip inc bioscrip to host second quarter results call july    bioscrip announces new senior note facilities june    bioscrip to present at the jefferies  global healthcare conference may    bioscrip reports first quarter  financial results may    bioscrip announces cfo transition april     other news releases in product  services announcement in the last  days profile bioscrip inc   subscribe via rss  subscribe via atom  javascript denver colorado united states contact data investor contacts stephen deitsch chief financial officer  treasurer t   stephendeitschbioscripcom david clair icr inc t   davidclairicrinccom contact with a reader account its easy to send email directly to the contact for this release sign up today for your free reader account already have an account log in here media files bioscrip inc logo logo url  copy the link below formats available original medium small newswire distribution network  management home newsroom rss feeds legal contact us about us globenewswire a nasdaq company is one of the worlds largest newswire distribution networks specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media investment community individual investors and the general public contact us corporate headquarters  rosecrans avenue suite  el segundo ca  phone   fax   european headquarters woolgate exchange  basinghall street london ecv ha uk phone     globenewswire inc all rights reserved